¿Los pobres hacen más demandas?

Same author

First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors.

ESMO open·2025

Same author

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Blood cancer journal·2015

Same author

An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Same author

The delayed diagnosis of breast cancer: medicolegal implications and risk prevention for surgeons.

Breast disease·2005

Same author

Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid.

Journal of the American College of Surgeons·2002

Same author

Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique.

Journal of the American College of Surgeons·2001

Same journal

Deaths Caused by Law Enforcement in the US.

JAMA·2026

Same journal

Hepatitis B.

JAMA·2026

Same journal

Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer.

JAMA·2026

Same journal

AI vs Poetry in Medicine.

JAMA·2026

Same journal

Rates of Precipitated Withdrawal in a Trial of ED-Initiated Buprenorphine for Opioid Use Disorder-Reply.

JAMA·2026

Same journal

New Lungs for Lung Cancer-Perils and Promises.

JAMA·2026

Videos de Experimentos Relacionados

¿Los pobres hacen más demandas?

Videos de Conceptos Relacionados

First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors.

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer.

The delayed diagnosis of breast cancer: medicolegal implications and risk prevention for surgeons.

Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid.

Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique.

Deaths Caused by Law Enforcement in the US.

Hepatitis B.

Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer.

AI vs Poetry in Medicine.

Rates of Precipitated Withdrawal in a Trial of ED-Initiated Buprenorphine for Opioid Use Disorder-Reply.

New Lungs for Lung Cancer-Perils and Promises.

Videos de Experimentos Relacionados

¿Los pobres hacen más demandas?

Videos de Conceptos Relacionados

Artículos Relacionados

First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors.

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer.

The delayed diagnosis of breast cancer: medicolegal implications and risk prevention for surgeons.

Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid.

Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique.

Deaths Caused by Law Enforcement in the US.

Hepatitis B.

Lung Transplant for Refractory Lung-Limited Stage IV Non-Small Cell Lung Cancer.

AI vs Poetry in Medicine.

Rates of Precipitated Withdrawal in a Trial of ED-Initiated Buprenorphine for Opioid Use Disorder-Reply.

New Lungs for Lung Cancer-Perils and Promises.